Robust designs in longitudinal studies accounting for parameter and model uncertainties – application to count data

References

• Atkinson, A. C. 2008. DT-optimum designs for model discrimination and parameter estimation. Journal of Statistical Planning and Inference 138 (1):56–64. doi:10.1016/j.jspi.2007.05.024.
   Web of Science ®Google Scholar
• Atkinson, A. C., A. Donev, and R. Tobias. 2009. Optimum experimental designs with SAS. Oxford: Oxford University Press.
   Google Scholar
• Bazzoli, C., S. Retout, and F. Mentré. 2009. Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model. Statistics in Medicine 28 (14):1940–1956. doi:10.1002/sim.v28:14.
   PubMed Web of Science ®Google Scholar
• Bornkamp, B. 2009. Mcpmod: an r package for the design and analysis of dose- finding studies. Journal Of Statistical Software 29 (7):1–23.
   Web of Science ®Google Scholar
• Buatois, S., S. Ueckert, N. Frey, S. Retout, and F. Mentré. 2018. Comparison of model averaging and model selection in dose finding trials analyzed by nonlinear mixed effect models. The AAPS Journal 20 (3):56. doi:10.1208/s12248-018-0205-x.
   PubMed Web of Science ®Google Scholar
• Chen, R.-B., S.-P. Chang, W. Wang, H.-C. Tung, and W. K. Wong. 2015. Minimax optimal designs via particle swarm optimization methods. Statistics and Computing 25 (5):975–988. doi:10.1007/s11222-014-9466-0.
   Web of Science ®Google Scholar
• Dumont, C., G. Lestini, H. Le Nagard, F. Mentré, E. Comets, and T. T. Nguyen, and the PFIM group (2018). PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models. Computer Methods and Programs in Biomedicine 156, 217-229.
   Google Scholar
• Dumont, C., M. Chenel, and F. Mentré. 2016. Two-stage adaptive designs in nonlinear mixed effects models: Application to pharmacokinetics in children. Communications in Statistics-Simulation and Computation 45 (5):1511–1525. doi:10.1080/03610918.2014.930901.
   Web of Science ®Google Scholar
• Fedorov, V. V., and S. L. Leonov. 2013. Optimal design for nonlinear response models. Boca Raton: Chapman and Hall/CRC Press.
   Google Scholar
• Foo, L. K., J. McGree, J. Eccleston, and S. Duffull. 2012. Comparison of robust criteria for D-optimal designs. Journal of Biopharmaceutical Statistics 22 (6):1193–1205. doi:10.1080/10543406.2011.580484.
   PubMed Web of Science ®Google Scholar
• Foo, L.-K., and S. Duffull. 2010. Methods of robust design of nonlinear models with an application to pharmacokinetics. Journal of Biopharmaceutical Statistics 20 (4):886–902. doi:10.1080/10543401003618918.
   PubMed Web of Science ®Google Scholar
• Gotwalt, C. M., B. A. Jones, and D. M. Steinberg. 2009. Fast computation of designs robust to parameter uncertainty for nonlinear settings. Technometrics 51 (1):88–95. doi:10.1198/TECH.2009.0009.
   Web of Science ®Google Scholar
• Jones, B., J. Wang, P. Jarvis, and W. Byrom. 1999. Design of cross-over trials for pharmacokinetic studies. Journal of Statistical Planning and Inference 78 (1–2):307–316. doi:10.1016/S0378-3758(98)00221-3.
   Web of Science ®Google Scholar
• Kiefer, J. 1974. General equivalence theory for optimum designs (approximate theory). The Annals of Statistics 2:849–879. doi:10.1214/aos/1176342810.
   Web of Science ®Google Scholar
• Kim, S., and L. Li. 2011. A novel global search algorithm for nonlinear mixed-effects models using particle swarm optimization. Journal of Pharmacokinetics and Pharmacodynamics 38 (4):471–495. doi:10.1007/s10928-011-9204-6.
   PubMed Web of Science ®Google Scholar
• Lestini, G., C. Dumont, and F. Mentré. 2015. Influence of the size of cohorts in adaptive design for nonlinear mixed effects models: An evaluation by simulation for a pharmacokinetic and pharmacodynamic model for a biomarker in oncology. Pharmaceutical Research 32 (10):3159–3169. doi:10.1007/s11095-014-1538-5.
   PubMed Web of Science ®Google Scholar
• Lestini, G., S. Ueckert, and F. Mentré. 2016. Robust design in model-based analysis of longitudinal clinical data. PODE 2016, Number Abstr 5. http://www.maths.qmul.ac.uk/bb/PODE/PODE2016.html.
   Google Scholar
• Maloney, A., U. S. Simonsson, and M. Schaddelee. 2013. D optimal designs for three poisson dose–Response models. Journal of Pharmacokinetics and Pharmacodynamics 40 (2):201–211. doi:10.1007/s10928-013-9300-x.
   PubMed Web of Science ®Google Scholar
• Marques, F. J., and F. Loingeville. 2016. Improved near-exact distributions for the product of independent generalized gamma random variables. Computational Statistics & Data Analysis 102:55–66. doi:10.1016/j.csda.2016.04.004.
   Web of Science ®Google Scholar
• Mentré, F., A. Mallet, and D. Baccar. 1997. Optimal design in random-effects regression models. Biometrika 84 (2):429–442. doi:10.1093/biomet/84.2.429.
   Web of Science ®Google Scholar
• Mould, D., and R. Upton. 2012. Basic concepts in population modeling, simulation, and model-based drug development. CPT: Pharmacometrics & Systems Pharmacology 1 (9):1–14.
   Google Scholar
• Mould, D., and R. Upton. 2013. Basic concepts in population modeling, simulation, and modelbased drug development: Part 2: Introduction to pharmacokinetic modeling methods. CPT: Pharmacometrics & Systems Pharmacology 2 (4):1–14.
   Google Scholar
• Nguyen, T. T., and F. Mentré. 2014. Evaluation of the fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature. Computational Statistics & Data Analysis 80:57–69. doi:10.1016/j.csda.2014.06.011.
   Web of Science ®Google Scholar
• Nguyen, T. T., H. Bénech, M. Delaforge, and N. Lenuzza. 2016. Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs. Pharmaceutical Statistics 15 (2):165–177. doi:10.1002/pst.v15.2.
   PubMed Web of Science ®Google Scholar
• Nyberg, J., M. O. Karlsson, and A. C. Hooker. 2009. Population optimal experimental design for discrete type data. PAGE 18, Number Abstr 1468. www.page-meeting.org/?abstract=1468.
   Google Scholar
• Ogungbenro, K., and L. Aarons. 2011. Population fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments. Journal of Pharmacokinetics and Pharmacodynamics 38 (4):449–469. doi:10.1007/s10928-011-9203-7.
   PubMed Web of Science ®Google Scholar
• Pan, J., and R. Thompson. 2007. Quasi-Monte Carlo estimation in generalized linear mixed models. Computational Statistics & Data Analysis 51 (12):5765–5775. doi:10.1016/j.csda.2006.10.003.
   Web of Science ®Google Scholar
• Pinheiro, J., B. Bornkamp, E. Glimm, and F. Bretz. 2014. Model-based dose finding under model uncertainty using general parametric models. Statistics in Medicine 33 (10):1646–1661. doi:10.1002/sim.6052.
   PubMed Web of Science ®Google Scholar
• Pronzato, L., and É. Walter. 1985. Robust experiment design via stochastic approximation. Mathematical Biosciences 75 (1):103–120. doi:10.1016/0025-5564(85)90068-9.
   Web of Science ®Google Scholar
• Pronzato, L., and A. Pázman. 2013. Design of experiments in nonlinear models. In design of experiments in nonlinear models, 212. doi:10.1007/978-1-4614-6363-4.
   Google Scholar
• Retout, S., E. Comets, C. Bazzoli, and F. Mentré. 2009. Design optimization in nonlinear mixed effects models using cost functions: Application to a joint model of infliximab and methotrexate pharmacokinetics. Communications in Statistics - Theory and Methods 38 (18):3351–3368. doi:10.1080/03610920902833511.
   Web of Science ®Google Scholar
• Riviere, M.-K., and F. Mentré. 2015. R package MIXFIM, version 1.0. https://cran.r-project.org/web/packages/MIXFIM/.
   Google Scholar
• Riviere, M.-K., S. Ueckert, and F. Mentré. 2016. An MCMC method for the evaluation of the fisher information matrix for non-linear mixed effect models. Biostatistics 17 (4):737–750. doi:10.1093/biostatistics/kxw020.
   PubMed Web of Science ®Google Scholar
• Russell, K.G., D.C. Woods, S.M. Lewis, and J.A. Eccleston (2009). D-optimal designs for Poisson regression models. Statistica Sinica, 19, 721–730
   Google Scholar
• Stan Development Team. 2016. RStan: The R interface to stan, version 2.12.0. http://mc-stan.org/.
   Google Scholar
• Ueckert, S., and F. Mentré (2015). Computation of the fisher information matrix for discrete non-linear mixed effect models. 8th International Conference of the ERCIM WG on Computational and Methodological Statistics (CMStatistics). University of London, UK.
   Google Scholar
• Ueckert, S., and F. Mentré. 2016. A new method for evaluation of the fisher information matrix for discrete mixed effect models using Monte Carlo sampling and adaptive Gaussian quadrature. Computational Statistics & Data Analysis 111:203–219. doi:10.1016/j.csda.2016.10.011.
   Web of Science ®Google Scholar
• Upton, R., and D. Mould. 2014. Basic concepts in population modeling, simulation, and model-based drug development: Part 3: Introduction to pharmacodynamic modeling methods. CPT: Pharmacometrics & Systems Pharmacology 3 (1):1–16.
   PubMedGoogle Scholar
• Walter, É., and L. Pronzato. 1987. Optimal experiment design for nonlinear models subject to large prior uncertainties. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 253 (3):R530–R534. doi:10.1152/ajpregu.1987.253.3.R530.
   Google Scholar
• Wedenberg, M. 2013. From cell survival to dose response: Modeling biological effects in radiation therapy. Solna, Sweden: Karolinska Universitetssjukhuset, Dept of Oncology-Pathology.
   Google Scholar